New PET Scan for Finding Cancers More Accurately
Part of Cancer clinical trials.
This study tests a new type of PET scan (a special imaging test) called 18F-FGIn to help doctors better detect and evaluate cancers. It may be more accurate than the standard PET scan for certain tumors like brain, liver, stomach, and colon cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected cancer or need to check if cancer has come back
- Your doctor wants to use a PET scan to stage your cancer or see how treatment is working
- You have never had another cancer before
- You are 18 years or older
- You can follow study instructions and are willing to give written consent
- You can tolerate and cooperate with a PET/CT scan (lying still for 30–60 minutes)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This study looks at different ways to measure the brightness of tumors on PET/CT scans. It aims to find which method is most accurate, which could improve how doctors read scans and plan treatment.
This trial tests a new type of PET/CT scan that uses a special tracer (called ⁶⁸Ga-FXX489) to help find and diagnose cancers. It is for people who are strongly suspected to have cancer and want to see if this new imaging method can help their doctors learn more about their disease.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.
This trial tests whether a special PET scan (FDG PET-CT) can better track how well treatment is working for people with advanced breast cancer. It may help doctors choose the best therapy and monitor response over time.
Hear when a new Cancer (With or Without Metastasis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.